PharmaVision's Drug Delivery and Device reports analyze the impact of advanced drug delivery systems and devices on approved and new products to optimize product life cycle management and reposition products. Increasingly the pharmaceutical industry utilizes novel formulations and delivery platforms earlier in the development process to overcome solubility and toxicities issues and improve biodistribution, pharmacokinetics and ease of use. In addition, generic and biogeneric manufacturers are applying advanced delivery technologies to differentiate their products to increase their foothold in the market. Each report analyzes key market trends, therapeutic developments and market leaders and provides detailed market forecasts for products and/or technologies.
PV AB & TP 08/10
PV RNAI DD 07/09
PV BIOPHAMA 01/09
PV SC DD 12/08
PV DD CNS 12/07
PV DD VAC 11/07
PV DD DIA 09/07